✦ LIBER ✦

Systemic toxicity of botulinum toxin by intramuscular injection in the monkey

✍ Scribed by Dr. Alan B. Scott; Dr. David Suzuki

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 168 KB
Volume: 3
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870030409

No coin nor oath required. For personal study only.

✦ Synopsis

Botulinum toxin (Oculinum) was injected intramuscularly into eight monkeys. The LD50 dose is estimated to be approximately 39 U/kg body weight. The lowest dose that caused systemic toxicity, 33 U/kg, was close to the fatal dose range, 38-42 U/kg.

📜 SIMILAR VOLUMES

Injection of the iliopsoas muscle with b

Injection of the iliopsoas muscle with botulinum toxin in camptocormia

✍ Carlo Colosimo; Filippo Maria Salvatori 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

How muscles recover from paresis and atr

How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats

✍ Jian Shen; Jianjun Ma; Cassandra Lee; Beth P. Smith; Thomas L. Smith; Kim H. Tan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 408 KB

## Abstract Botulinum toxin A (BoNT‐A) is a potent biological toxin widely used for the management of skeletal muscle spasticity or dynamic joint contracture. Intramuscular injection of BoNT‐A causes muscle denervation, paresis, and atrophy. This clinical effect of botulinum toxin A lasts 3 to 6 mo

Ultrasound-guided injection of the iliop

Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia

✍ Rainer von Coelln; Armin Raible; Thomas Gasser; Friedrich Asmus 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract Camptocormia is characterized by an abnormal posture of the trunk with pronounced flexion of the thoraco‐lumbar spine during standing and walking, which abates in a supine position. Treatment options for camptocormia are limited and mostly futile. Here, we report on the ultrasound‐guide

Assay of Digitalis by Intramuscular Inje

Assay of Digitalis by Intramuscular Injection in the Frog

✍ Dooley, M.S. ;Higley, C.D. 📂 Article 📅 1922 🏛 Elsevier ⚖ 562 KB

Secondary nonresponsiveness to botulinum

Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test

✍ Carla Cordivari; Vijay Peter Misra; Angela Vincent; Santiago Catania; Kailash P. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract We studied 20 patients with cervical dystonia who had started to respond poorly to botulinum toxin A (BTXA) injections after an initial good response. All patients had extensor digitorum brevis (EDB) tests performed in addition to BTXA immunoprecipition assay (IPA) and mouse bioassay (M

Variability of the immunologic and clini

Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections

✍ Charulata Sankhla; Dr. Joseph Jankovic; Drake Duane 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Immunoresistance (Ab+) to botulinum toxin type A (BTX-A) has been a serious concern since the introduction of BTX-A in the treatment of dystonia and other disorders associated with abnormal muscle contractions. We studied seven patients who developed Ab+ and later reverted to antibody-negative (Ab-)